Xtant Medical (XTNT) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for November 7, 2025, at 8:00 a.m. ET in New York, NY.
Shareholders can vote online, by mail, or in person, with a deadline of November 6, 2025, for online voting.
Proxy materials, including the Notice, Proxy Statement, and Form 10-K, are available online or by request.
Voting matters and shareholder proposals
Election of six director nominees to serve until the next annual meeting.
Ratification of Grant Thornton LLP as independent auditor for the year ending December 31, 2025.
Approval of an amendment to the 2023 Equity Incentive Plan.
Advisory vote on executive officer compensation (say-on-pay).
Advisory vote on the frequency of future say-on-pay votes.
Board of directors and corporate governance
Six nominees listed for election to the board: John Bakewell, Jonn Beeson, Sean E. Browne, Abhinav Jain, Tyler P. Lipschultz, and Stavros Vizirgianakis.
Latest events from Xtant Medical
- Vertical integration, innovation, and divestitures drive growth and profitability.XTNT
2026 CG Musculoskeletal Conference2 Mar 2026 - Growth, margin expansion, and strategic M&A position the business for strong future performance.XTNT
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase2 Feb 2026 - Q2 2024 revenue up 48% to $29.9M, with positive Adjusted EBITDA and strong outlook.XTNT
Q2 20241 Feb 2026 - Q3 revenue up 12% to $27.9M, net loss $5.0M, guidance reaffirmed at $116M–$120M.XTNT
Q3 202414 Jan 2026 - 2024 revenue up 28% to $117.3M; 2025 guidance $126–$130M, free cash flow expected.XTNT
Q4 202424 Dec 2025 - Registration enables resale of 7.8M shares; no proceeds to company; significant dilution risk.XTNT
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, auditor, equity plan, and executive pay, with Board support.XTNT
Proxy Filing2 Dec 2025 - Annual meeting to elect directors, ratify auditor, and approve executive pay, with strong governance.XTNT
Proxy Filing2 Dec 2025 - 73.1M shares registered for resale after a control shift; no proceeds to company, high market risk.XTNT
Registration Filing29 Nov 2025